Abstract
Natural products from animal venoms have been used widely in the discovery of novel molecules with particular biological activities that enable their use as potential drug candidates. The phylum Cnidaria (jellyfish, sea anemones, corals zoanthids, hydrozoans, etc.) is the most ancient venomous phylum on earth. Its venoms are composed of a complex mixture of peptidic compounds with neurotoxic and cytolitic properties that have shown activity on mammalian systems despite the fact that they are naturally targeted against fish and invertebrate preys, mainly crustaceans. For this reason, cnidarian venoms are an interesting and vast source of molecules with a remarkable activity on central nervous system, targeting mainly voltage-gated ion channels, ASIC channels, and TRPV1 receptors. In this brief review, we list the amino acid sequences of most cnidarian neurotoxic peptides reported to date. Additionally, we propose the inclusion of a new type of voltage-gated sea anemone sodium channel toxins based on the most recent reports.
Keywords: Cnidaria, venom, neurotoxin, peptides, ion channels, TRPV1..
Central Nervous System Agents in Medicinal Chemistry
Title:Cnidarian Neurotoxic Peptides Affecting Central Nervous System Targets
Volume: 16 Issue: 3
Author(s): Fernando Lazcano-Pérez, Ulises Hernández-Guzmán, Judith Sánchez-Rodríguez and Roberto Arreguín-Espinosa
Affiliation:
Keywords: Cnidaria, venom, neurotoxin, peptides, ion channels, TRPV1..
Abstract: Natural products from animal venoms have been used widely in the discovery of novel molecules with particular biological activities that enable their use as potential drug candidates. The phylum Cnidaria (jellyfish, sea anemones, corals zoanthids, hydrozoans, etc.) is the most ancient venomous phylum on earth. Its venoms are composed of a complex mixture of peptidic compounds with neurotoxic and cytolitic properties that have shown activity on mammalian systems despite the fact that they are naturally targeted against fish and invertebrate preys, mainly crustaceans. For this reason, cnidarian venoms are an interesting and vast source of molecules with a remarkable activity on central nervous system, targeting mainly voltage-gated ion channels, ASIC channels, and TRPV1 receptors. In this brief review, we list the amino acid sequences of most cnidarian neurotoxic peptides reported to date. Additionally, we propose the inclusion of a new type of voltage-gated sea anemone sodium channel toxins based on the most recent reports.
Export Options
About this article
Cite this article as:
Lazcano-Pérez Fernando, Hernández-Guzmán Ulises, Sánchez-Rodríguez Judith and Arreguín-Espinosa Roberto, Cnidarian Neurotoxic Peptides Affecting Central Nervous System Targets, Central Nervous System Agents in Medicinal Chemistry 2016; 16 (3) . https://dx.doi.org/10.2174/1871524915666150722120915
DOI https://dx.doi.org/10.2174/1871524915666150722120915 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Analytical Models For Genetics of Human Traits Influenced By Sex
Current Genomics Central Nervous System Agents Used as Trypanosoma cruzi Infection Chemotherapy: Phenothiazines and Related Compounds
Current Medicinal Chemistry - Anti-Infective Agents Oxidant/Antioxidant Imbalance and the Risk of Alzheimer's Disease
Current Alzheimer Research “Speed” Warps Time: Methamphetamines Interactive Roles in Drug Abuse, Habit Formation, and the Biological Clocks of Circadian and Interval Timing
Current Drug Abuse Reviews Stroke in Women
Recent Patents on Cardiovascular Drug Discovery Response to Treatment with Placebo, Medication or Psychotherapy in Severe Non- Psychotic Major Depressive Disorder
Current Psychiatry Reviews Bioorganic Compounds Produced by the Fungus Monascus and their Use in Health Sciences and Medicine
Mini-Reviews in Organic Chemistry Glucocorticoids in Pregnancy
Current Pharmaceutical Biotechnology Presenilin 1 and APP Gene Mutations in Early-Onset AD Families from a Southeast Region of China
Current Alzheimer Research Jun Dimerization Protein 2: A Multifunctional Transcription Factor in Mammalian Cells
Current Genomics In Vivo Bio-imaging Using Chlorotoxin-based Conjugates
Current Pharmaceutical Design A Central Role for ATP Signalling in Glial Interactions in the CNS
Current Drug Targets Rhodanine as a Privileged Scaffold in Drug Discovery
Current Medicinal Chemistry GSK-3 Inhibitors: A New Class of Drugs for Alzheimer’s Disease Treatment
Current Drug Targets New Insights into the Treatment of Multiple Myeloma with Histone Deacetylase Inhibitors
Current Pharmaceutical Design Evaluation of Pregabalin Therapy in Peripheral Neuropathy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Omega – 3 Fatty Acids as Pharmacotherapeutics in Psoriasis: Current Status and Scope of Nanomedicine in its Effective Delivery
Current Drug Targets Can Diabetes Heal?- From Observations to Perspectives
Current Diabetes Reviews Targeting FGFR with BGJ398 in Breast Cancer: Effect on Tumor Growth and Metastasis
Current Cancer Drug Targets Central Nervous System Activities of Indole Derivatives: An Overview
Central Nervous System Agents in Medicinal Chemistry